Author: afirm4

Targeting the Endotheliopathy of Trauma (EOT) with Lyophilized Mesenchymal Stem Cells (MSCs) and Lyophilized MSC Extracellular Vesicles (EVs)

Principal Investigator: Shibani Pati, MD, PhDOrganization: University of California San Francisco The main goal of this project is to develop and test dried stem cell products (lyophilized-MSCs and lyophilized-MSC EVs) for their potential to attenuate the Endotheliopathy of Trauma and mitigate outcomes in severely injured patients in need of pre-hospital care. The rationale for the […]

Human Amnion Membrane Product (hAMP) for Treatment of Burn Wounds in Remote, Pre-hospital Setting

Principal Investigators: Shay Soker, PhD; Co-PI Sean Murphy, PhDOrganization: Wake Forest University Health Sciences Given the unpredictable future battle and casualty management environment, with definitive burn treatment occurring only post-evacuation, there is a need for effective and comprehensive trauma wound treatment capabilities deployable prehospital. Biological products such as amnion membrane shown efficacy in accelerating wound […]